4.4 Article

Direct Capture of Functional Proteins from Mammalian Plasma Membranes into Nanodiscs

期刊

BIOCHEMISTRY
卷 54, 期 41, 页码 6299-6302

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.biochem.5b00954

关键词

-

资金

  1. Campus Research Board, American Heart Association
  2. Office of the Provost, University of Illinois at Urbana-Champaign

向作者/读者索取更多资源

Mammalian plasma membrane proteins make up the largest class of drug targets yet are difficult to study in a cell free system because of their intransigent nature. Herein, we perform direct encapsulation of plasma membrane proteins derived from mammalian cells into a functional nanodisc library. Peptide fingerprinting was used to analyze the proteome of the incorporated proteins in nanodiscs and to further demonstrate that the lipid composition of the nanodiscs directly affects the class of protein that is incorporated. Furthermore, the functionality of the incorporated membrane proteome was evaluated by measuring the activity of membrane proteins: Na+/K+-ATPase and receptor tyrosine kinases. This work is the first report of the successful establishment and characterization of a cell free functional library of mammalian membrane proteins into nanodiscs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression

Timothy M. Fan, Ryan D. Roberts, Michael M. Lizardo

FRONTIERS IN ONCOLOGY (2020)

Article Veterinary Sciences

Rabacfosadine for naive canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials

Corey F. Saba, Craig Clifford, Kristine Burgess, Brenda Phillips, David Vail, Zachary Wright, Katie Curran, Timothy Fan, Robyn Elmslie, Gerald Post, Douglas Thamm

VETERINARY AND COMPARATIVE ONCOLOGY (2020)

Article Oncology

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

Amy K. LeBlanc, Christina N. Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown, Susan E. Lana, Kristen Weishaar, Brian K. Flesner, Jeffrey N. Bryan, David M. Vail, Jenna H. Burton, Jennifer L. Willcox, Anthony J. Mutsaers, J. Paul Woods, Nicole C. Northrup, Corey Saba, Kaitlin M. Curran, Haley Leeper, Heather Wilson-Robles, Brandan G. Wustefeld-Janssens, Stephanie Lindley, Annette N. Smith, Nikolaos Dervisis, Shawna Klahn, Mary Lynn Higginbotham, Raelene M. Wouda, Erika Krick, Jennifer A. Mahoney, Cheryl A. London, Lisa G. Barber, Cheryl E. Balkman, Angela L. McCleary-Wheeler, Steven E. Suter, Olya Martin, Antonella Borgatti, Kristine Burgess, Michael O. Childress, Janean L. Fidel, Sara D. Allstadt, Daniel L. Gustafson, Laura E. Selmic, Chand Khanna, Timothy M. Fan

Summary: Using sirolimus as an mTOR inhibitor in treating appendicular osteosarcoma in pet dogs did not extend disease-free interval or survival.

CLINICAL CANCER RESEARCH (2021)

Article Pharmacology & Pharmacy

Pharmacokinetics of a cytosine arabinoside subcutaneous protocol in dogs with meningoencephalomyelitis of unknown aetiology

Hilary A. Levitin, Kari D. Foss, Zhong Li, Jennifer M. Reinhart, Devon W. Hague, Timothy M. Fan

Summary: This study compared the pharmacokinetics of subcutaneous (SC) and constant rate infusion (CRI) protocols of cytosine arabinoside (CA) in dogs with meningoencephalomyelitis of unknown aetiology (MUE). The SC protocol showed significantly higher peak CA concentration and sustained levels compared to the CRI protocol, with higher concentrations observed at 1h and 8h following treatment initiation.

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2021)

Article Oncology

Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients

Emily J. Tonogai, Shan Huang, Rachel C. Botham, Matthew R. Berry, Stephen K. Joslyn, Gregory B. Daniel, Zixin Chen, Jianghong Rao, Xiang Zhang, Falguni Basuli, John H. Rossmeisl, Gregory J. Riggins, Amy K. LeBlanc, Timothy M. Fan, Paul J. Hergenrother

Summary: The study found that PAC-1 + TMZ may be an effective combination for treating meningioma, and the participation of pet dogs with meningioma in the study also demonstrated the utility of evaluating anticancer strategies.

NEURO-ONCOLOGY (2021)

Article Cell Biology

A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice

Matthew W. Boudreau, Darjan Duraki, Lawrence Wang, Chengjian Mao, Ji Eun Kim, Madeline A. Henn, Bingtao Tang, Sean W. Fanning, Jeffrey Kiefer, Theodore M. Tarasow, Elizabeth M. Bruckheimer, Ramon Moreno, Spyro Mousses, Geoffrey L. Greene, Edward J. Roy, Ben Ho Park, Timothy M. Fan, Erik R. Nelson, Paul J. Hergenrother, David J. Shapiro

Summary: The compound ErSO was discovered to effectively induce necrosis of ERα-positive breast cancer cell lines and trigger tumor regression in vivo, including regression of metastases. ErSO was well tolerated in mice, rats, and dogs and had minimal impact on normal tissues expressing ER.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Oncology

Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy

Alycen P. Lundberg, Matthew W. Boudreau, Kim A. Selting, Lindsay E. Chatkewitz, Jonathan Samuelson, Joshua M. Francis, Elizabeth I. Parkinson, Anne M. Barger, Paul J. Hergenrother, Timothy M. Fan

Summary: Developing effective therapies for advanced head-and-neck squamous cell carcinoma (HNSCC) is challenging, with NQO1 being a promising target. This study involves preclinical assessment using felines and FOSCC patients to identify potential drugs with increased tolerability and efficacy.

NEOPLASIA (2021)

Article Biochemistry & Molecular Biology

Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture

Riley L. Svec, Sydney A. McKee, Matthew R. Berry, Aya M. Kelly, Timothy M. Fan, Paul J. Hergenrother

Summary: This article describes a novel compound, CPZ, which shows promising activity against GBM by overcoming MGMT resistance and being effective regardless of MMR status. CPZ has better blood-brain barrier penetration and comparable tolerability to TMZ, making it a potential candidate for GBM treatment, especially in TMZ-resistant cases.

ACS CHEMICAL BIOLOGY (2022)

Article Pharmacology & Pharmacy

Osteosarcoma mechanobiology and therapeutic targets

Zunaira Shoaib, Timothy M. Fan, Joseph M. K. Irudayaraj

Summary: Osteosarcoma, a common primary bone tumor, is influenced by mechanobiology in its pathogenesis. Mechanobiology-driven therapies can curb tumor progression by altering the physical microenvironment or inhibiting proteins associated with metastasis.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Chemistry, Medicinal

Activators of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer

Matthew W. Boudreau, Michael P. Mulligan, David J. Shapiro, Timothy M. Fan, Paul J. Hergenrother

Summary: Approximately 75% of breast cancers are ER alpha-positive, and current therapeutic strategies targeting ER alpha have limitations. A recent study identified a compound called ErSO that induces ER alpha-dependent cancer cell death through a unique mechanism and shows potential as a new drug. Modified versions of ErSO were constructed and one variant, ErSO-DFP, demonstrated enhanced selectivity for ER alpha-positive cancer cells and good tolerability in rodents. ErSO-DFP and related compounds may represent a novel class of treatments for ER alpha-positive cancers.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants

Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, Matthew Chan, Kui K. Chan, Timothy M. Fan, Keith L. Bailey, Matthew Lindeblad, Laura M. Cooper, Lijun Rong, Anthony F. Gugliuzza, Diwakar Shukla, Erik Procko, Jalees Rehman, Asrar B. Malik

Summary: This study demonstrates that engineered ACE2 proteins with augmented binding affinities for SARS-CoV-2 spike protein show broad efficacy against multiple variants, indicating their therapeutic potential.

NATURE CHEMICAL BIOLOGY (2022)

Review Oncology

Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer

Samantha K. Von Rueden, Timothy M. Fan

Summary: The interplay between tumor and immune response is a dynamic process that determines the formation and growth of tumors through various mechanisms. Understanding the continuous adaptation of tumor and host immune systems throughout the tumor lifecycle is crucial for developing effective immunotherapies. This review summarizes the steps of the cancer-immunity cycle and highlights key factors that favor cancer regression for optimizing treatment outcomes.

FRONTIERS IN ONCOLOGY (2021)

Article Engineering, Biomedical

Characterization of Anti-Angiogenic Chemo-Sensitization via Longitudinal Ultrasound Localization Microscopy in Colorectal Carcinoma Tumor Xenografts

Matthew R. Lowerison, Wei Zhang, Xi Chen, Timothy M. Fan, Pengfei Song

Summary: In this paper, the authors applied super-resolution ultrasound localization microscopy (ULM) to study the effects of antiangiogenic agent and chemotherapy on colorectal carcinoma xenograft model. The results demonstrated that ULM can detect vascular changes caused by the treatments and provide quantitative indices for evaluating therapy response. The study highlights the importance of ULM in evaluating treatment effect.

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2022)

Article Pathology

The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs

Anne Barger, Kate Baker, Elizabeth Driskell, Will Sander, Patrick Roady, Matthew Berry, Amy Schnelle, Timothy M. Fan

Summary: This study evaluated the ability of four immunohistochemistry markers to distinguish osteosarcoma from other primary bone tumors. The combination of alkaline phosphatase (ALP) and runx2 showed high sensitivity and specificity, making them useful for diagnostic purposes.

VETERINARY PATHOLOGY (2022)

Article Nutrition & Dietetics

A 10% Tomato Diet Selectively Reduces Radiation-Induced Damage in TRAMP Mice

Joe L. Rowles, Matthew A. Wallig, Kimberly A. Selting, Timothy M. Fan, Rita J. Miller, William D. O'Brien, John W. Erdman

Summary: The study showed that dietary lyophilized tomato paste (TP) reduced radiation-induced apoptosis in nonneoplastic tissues in TRAMP mice, without affecting apoptosis within the prostate tumor. Further studies are needed to confirm and expand upon these findings.

JOURNAL OF NUTRITION (2021)

暂无数据